Dr. Joseph Nesheiwat is a rheumatologist in Baton Rouge,Louisiana.
Male
1417061912
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Injections of tendon sheath, ligament, or muscle membrane | 13.0 | 11.0 | 115.0 |
| Aspiration and/or injection of small joint or joint capsule | 13.0 | 12.0 | 150.0 |
| Aspiration and/or injection of large joint or joint capsule | 74.0 | 53.0 | 214.05405405 |
| Insertion of needle into vein for collection of blood sample | 227.0 | 156.0 | 9.0 |
| Blood test, comprehensive group of blood chemicals | 34.0 | 31.0 | 52.0 |
| Liver function blood test panel | 112.0 | 75.0 | 64.0 |
| Albumin (protein) level | 14.0 | 14.0 | 18.0 |
| Calcium level | 32.0 | 31.0 | 18.0 |
| Creatine kinase (cardiac enzyme) level | 20.0 | 14.0 | 32.0 |
| Blood creatinine level | 126.0 | 90.0 | 21.0 |
| Glutamyltransferase (liver enzyme) level | 12.0 | 11.0 | 25.0 |
| Magnesium level | 13.0 | 13.0 | 28.0 |
| Blood test, thyroid stimulating hormone (TSH) | 16.0 | 16.0 | 67.0 |
| Uric acid level, blood | 41.0 | 36.0 | 18.0 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 137.0 | 90.0 | 30.0 |
| Red blood cell sedimentation rate, to detect inflammation | 175.0 | 130.0 | 17.0 |
| Screening test for autoimmune disorder | 21.0 | 21.0 | 57.0 |
| Measurement C-reactive protein for detection of infection or inflammation | 175.0 | 131.0 | 16.0 |
| Measurement of complement (immune system proteins) | 32.0 | 16.0 | 34.0 |
| Measurement of antibody for rheumatoid arthritis assessment | 24.0 | 24.0 | 37.0 |
| Measurement of DNA antibody | 14.0 | 14.0 | 48.0 |
| Measurement of antibody for assessment of autoimmune disorder | 72.0 | 12.0 | 33.0 |
| Rheumatoid factor level | 30.0 | 30.0 | 27.0 |
| Hepatitis C antibody measurement | 27.0 | 27.0 | 40.0 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 29.0 | 18.0 | 47.0 |
| Infusion of chemotherapy into a vein up to 1 hour | 242.0 | 35.0 | 304.0 |
| New patient office or other outpatient visit, typically 45 minutes | 114.0 | 114.0 | 267.0 |
| New patient office or other outpatient visit, typically 60 minutes | 12.0 | 12.0 | 333.0 |
| Established patient office or other outpatient visit, typically 15 minutes | 143.0 | 114.0 | 117.30769231 |
| Established patient office or other outpatient, visit typically 25 minutes | 533.0 | 300.0 | 173.55347092 |
| Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when perfor | 15.0 | 15.0 | 50.0 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9850.0 | 13.0 | 54.0 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 51.0 | 18.0 | 10.0 |
| Injection, methylprednisolone acetate, 40 mg | 94.0 | 46.0 | 13.0 |
| Injection, methylprednisolone acetate, 80 mg | 28.0 | 22.0 | 21.0 |
| Injection, golimumab, 1 mg, for intravenous use | 8622.0 | 13.0 | 50.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.